FR1336M - Médicament anti-inflammatoire et hémostatique, son utilisation comme adjuvant au traitement des infections et compositions thérapeutiques constituées en vue d'une telle utilisation. - Google Patents

Médicament anti-inflammatoire et hémostatique, son utilisation comme adjuvant au traitement des infections et compositions thérapeutiques constituées en vue d'une telle utilisation.

Info

Publication number
FR1336M
FR1336M FR870697A FR870697A FR1336M FR 1336 M FR1336 M FR 1336M FR 870697 A FR870697 A FR 870697A FR 870697 A FR870697 A FR 870697A FR 1336 M FR1336 M FR 1336M
Authority
FR
France
Prior art keywords
infections
adjuvant
inflammatory
treatment
therapeutic compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR870697A
Other languages
English (en)
Inventor
Donald A Hoff
Alan R Wagner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warren-Teed Products Co
Original Assignee
Warren-Teed Products Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warren-Teed Products Co filed Critical Warren-Teed Products Co
Application granted granted Critical
Publication of FR1336M publication Critical patent/FR1336M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR870697A 1960-08-15 1961-08-11 Médicament anti-inflammatoire et hémostatique, son utilisation comme adjuvant au traitement des infections et compositions thérapeutiques constituées en vue d'une telle utilisation. Expired FR1336M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49446A US3041237A (en) 1960-08-15 1960-08-15 Systemic composition for the reduction of inflammation and edema and method of administering

Publications (1)

Publication Number Publication Date
FR1336M true FR1336M (fr) 1962-05-28

Family

ID=21959860

Family Applications (1)

Application Number Title Priority Date Filing Date
FR870697A Expired FR1336M (fr) 1960-08-15 1961-08-11 Médicament anti-inflammatoire et hémostatique, son utilisation comme adjuvant au traitement des infections et compositions thérapeutiques constituées en vue d'une telle utilisation.

Country Status (2)

Country Link
US (1) US3041237A (fr)
FR (1) FR1336M (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2469179A1 (fr) * 1979-11-08 1981-05-22 Beecham Group Ltd Composition pharmaceutique pour injection renfermant une penicilline

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3288675A (en) * 1964-03-20 1966-11-29 Hoffmann La Roche Parenteral sulfonamide compositions and processes
US4897426A (en) * 1986-03-06 1990-01-30 New York University Method for blocking calcium channels
WO1987005214A1 (fr) * 1986-03-06 1987-09-11 New York University Procede de blocage de canaux de calcium

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2297079A (en) * 1940-08-17 1942-09-29 Lilly Co Eli Solution of chemotherapeutic agents in ethylidene glycerol
US2369711A (en) * 1942-03-17 1945-02-20 Smith Kline French Lab Medicinal preparation
US2566066A (en) * 1948-10-11 1951-08-28 Irving W Martin Method of preparing a hydrochloride of a sulfa drug composition for poultry
US2635980A (en) * 1950-02-11 1953-04-21 Wm S Merrell Co Stabilized sulfa drug

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2469179A1 (fr) * 1979-11-08 1981-05-22 Beecham Group Ltd Composition pharmaceutique pour injection renfermant une penicilline
EP0029668A1 (fr) * 1979-11-08 1981-06-03 Beecham Group Plc Composition pharmaceutique injectable et récipient double de conditionnement pour cette composition

Also Published As

Publication number Publication date
US3041237A (en) 1962-06-26

Similar Documents

Publication Publication Date Title
OA01009A (fr) Préparation d'urée.
FR1593M (fr) Compositions pour le traitement de l'acne.
FR1336M (fr) Médicament anti-inflammatoire et hémostatique, son utilisation comme adjuvant au traitement des infections et compositions thérapeutiques constituées en vue d'une telle utilisation.
FR1131M (fr) Utilisation d'une gaze en polyoléfine.
FR1715M (fr) Composition thérapeutique.
FR2338M (fr) Nouveaux remedes destinés notamment au traitement des céphalées d'origine vasculaire.
FR1443M (fr) Préparation dermatologique.
BE605476A (fr) Composition vétérinaire pour le traitement de l'entérohépatite chez le dindon
BE599006A (fr) Complexe de Werner et sa préparation.
FR1489M (fr) Diphénlysulfones substituées en 4,4' et leurs préparations pharmaceutiques pour le traitement des maladies virales.
FR1334211A (fr) Composition destinée au traitement des vins
FR3392M (fr) Médicament dermatologique, notamment pour le traitement de l'eczéma suintant.
CH384782A (fr) Canule pour applications médicales
FR1274141A (fr) Perfectionnement au traitement des corps gras, en particulier des sulforicinates
FR1224M (fr) Traitement homéoflore des glandes sébacées.
BE607685A (fr) Préparation de 1,2-diphényl-4-carbamoyl-3,5 pyrazolidinedione.
FR1037M (fr) Médicament destiné au traitement des aérocolies, du météorisme et des gastralgies.
BE611474A (fr) Composition thérapeutique pour le traitement des collagénoses et autres affections analogues.
FR9F (fr) Applications thérapeutiques de l'arginase (corps 45-25c).
FR8F (fr) Applications thérapeutiques de l'arginase corps 45-25c.
FR385M (fr) Nouveau médicament pour le traitement des infections staphylococciques et analogues.
BE597411A (fr) Compositions pharmaceutiques destinées au traitement de l'épilepsie.
FR3777M (fr) Nouveau médicament protecteur et adjuvant de la corticothérapie, destiné également au traitement des hypokaliémies d'origines diverses.
CA606356A (en) Therapeutic compositions for the treatment of the scalp
BE591489A (fr) Agent de cicatrisation.